Research Archive — Page 1 of 133

June 5, 2026

Research addresses barriers to success for antibody-based therapies for solid head, neck and pancreatic tumors

A new platform allows visualization of drug-tumor interactions in human solid tumors, providing a tool for measuring drug delivery and signaling.

June 5, 2026

New research: Heart drug may also limit the spread of cancer

For the past 20 years, Vanderbilt Health researchers have been studying ifetroban for its potential to treat conditions ranging from fibrotic lung disease to heart failure in patients with Duchene muscular dystrophy.

June 3, 2026

Study finds link between neighborhood opportunity and mental health-related hospitalizations in youths

Opportunity is measured by the Child Opportunity Index 3.0, a publicly available, multidimensional metric that captures neighborhood conditions that influence children’s health, like education, housing, access to healthy food, environment and societal factors.

June 3, 2026

Study questions standard screening test for amputation risk in veterans

In a review of the electronic health records of more than 223,000 veterans treated at Veterans Health Administration facilities, the researchers found that even modest decreases in the normal ABI correlated with a higher risk of major adverse limb events (MALE) requiring intervention, including amputation and revascularization (treatment to restore blood flow).

Photo of the exterior of Monroe Carell Jr. Children's Hospital at Vanderbilt shows the four new floors added atop the pediatric facility. (photo by Anne Rayner)
June 3, 2026

Study challenges long-held practice of imaging for foreign body aspirations

As aspiration cases at Monroe Carell Jr. Children’s Hospital at Vanderbilt grew, a team of physicians sought to ensure that the most appropriate imaging tools were being used in the evaluation and diagnostic process for suspected aspirations.

June 1, 2026

Vanderbilt ALS Research Center hosts second Reporting the Research event

Attendees gathered at Fat Bottom Brewing Company on May 20 for the event to raise awareness about the neurodegenerative disorder, amyotrophic lateral sclerosis (ALS).